• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.27% Nasdaq Up 1.34%

    Curis, Inc. (CRIS)

    -NasdaqGM
    1.20 Up 0.08(7.15%) 9:42AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.12
    Open:N/A
    Bid:1.10 x 200
    Ask:1.30 x 21000
    1y Target Est:5.43
    Beta:0.95
    Earnings Date:Feb 18 - Feb 23 (Est.)
    Day's Range:1.09 - 1.21
    52wk Range:1.09 - 3.40
    Volume:92,754
    Avg Vol (3m):350,236
    Market Cap:103.21M
    P/E (ttm):N/A
    EPS (ttm):-0.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CRISUp 7.15%103.21M
    EXELUp 1.47%269.40M
    INFIDown 0.94%818.29M
    PFEUp 1.80%199.60B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.22
    Quarterly EPS Est (Dec-14) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback